KMT2A and acute myeloid leukemia: Our study was designed to specifically interrogate the effect of altered protein expression in AML progression by combining RNA-sequencing (RNA-seq) techniques with a quantitative mass spectrometry (MS) analysis in mouse models of AML: CBFB::MYH11 (Inv(16)), MLL::AF9, and MLL::ENL.